prednisolone 2 MG/ML Oral Solution

What the CMS Formulary Data Shows for prednisolone 2 MG/ML Oral Solution

Per the CMS 2026 Part D formulary file, prednisolone 2 MG/ML Oral Solution (RxNorm concept RXCUI 794979, generic name prednisolone) appears on 34 distinct formulary files spanning 902 Medicare Part D plan offerings - 17.8% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 2.

Real-world access to prednisolone 2 MG/ML Oral Solution depends on utilization management as much as tier placement: 29.4% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 20,337 Part D beneficiaries filled prednisolone 2 MG/ML Oral Solution in 2023, with total plan-and-beneficiary spending of $1,319,595 and an average per-beneficiary annual cost of $64.89. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry prednisolone 2 MG/ML Oral Solution today.